Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Revenue

In the fiscal year ending June 30, 2026, Neuphoria Therapeutics had annual revenue of $1.17M, down -92.50%. Neuphoria Therapeutics had revenue of $1.17M in the quarter ending June 30, 2026.

• Revenue (ttm): $1.17M
• Revenue Growth: -92.50%
• P/S Ratio: 17.05
• Revenue / Employee: $146,771
• Employees: 8
• Market Cap: 20.02M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.17M	-14.48M	-92.50%
Jun 30, 2025	15.65M	-	-
Jun 30, 2024	-	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	4.17M	3.48M	499.60%

Data Source: S&P Global Market Intelligence Last updated: Sep 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error